Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells

Growth hormone-releasing hormone (GHRH) and its receptors are expressed in a variety of human cancers, and have been involved in malignancies. GHRH antagonists (GHRHAnt) were developed to suppress tumor progression and metastasis. Previous studies demonstrate the involvement of reactive oxygen speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubra, Khadeja-Tul, Akhter, Mohammad S., Apperley, Kaitlyn, Barabutis, Nektarios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762825/
https://www.ncbi.nlm.nih.gov/pubmed/36540765
http://dx.doi.org/10.3390/endocrines3040067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762825/
https://www.ncbi.nlm.nih.gov/pubmed/36540765
http://dx.doi.org/10.3390/endocrines3040067

Ejemplares similares